Clinical Research Directory
Browse clinical research sites, groups, and studies.
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Sponsor: Rhode Island Hospital
Summary
The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no alternative to this injection medicine. This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid injection. The difference between Botox and steroid injections is that they are different medicines and work in different ways. Botox, as it is being used in this study, is not FDA-approved. It is therefore considered an investigational medicine.
Official title: Botulinum Toxin Injection in the Management of Thumb Carpometacarpal Arthritis: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-08-27
Completion Date
2026-07
Last Updated
2024-11-20
Healthy Volunteers
No
Interventions
Botulinum toxin
Patients in this group will receive an injection of Botulinum toxin.
Standard-of-care corticosteroid injections
Patients in this group will receive an injection of corticosteroid injections, which are considered standard of care.
Locations (1)
235 Plain Street
Providence, Rhode Island, United States